Cargando…

Dynamic prediction modeling for cancer‐associated venous thromboembolism

Detalles Bibliográficos
Autor principal:	van Es, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317198/ https://www.ncbi.nlm.nih.gov/pubmed/32496017 http://dx.doi.org/10.1111/jth.14803

Ejemplares similares

Clinical prediction scores for venous thromboembolism in patients with a hematological malignancy
por: Mulder, Frits I., et al.
Publicado: (2018)

Prediction of venous thromboembolism in patients with lower-limb immobilization
por: Di Nisio, Marcello, et al.
Publicado: (2020)

Venous thromboembolism deserves your attention
por: Marc Samama, Charles
Publicado: (2001)

Preventing venous thromboembolism without causing harm
por: Holley, Aaron B
Publicado: (2020)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
por: Moik, Florian, et al.
Publicado: (2020)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Commentary on “Risk of venous thromboembolism after COVID‐19 vaccination”
por: Frere, Corinne, et al.
Publicado: (2022)

Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism
por: Juneja, Manu, et al.
Publicado: (2023)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Prophylaxis of venous thromboembolism in medical patients: too much or too little?
por: Christiansen, Christian Fynbo
Publicado: (2012)

Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia
por: Middeldorp, Saskia
Publicado: (2023)

Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study
por: Sørensen, Henrik Toft, et al.
Publicado: (2023)

Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management
por: Giustozzi, Michela, et al.
Publicado: (2020)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
por: Wojta, Johann
Publicado: (2022)

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
por: van Es, Nick, et al.
Publicado: (2017)

Application of Machine Learning to the Prediction of Cancer-Associated Venous Thromboembolism
por: Mantha, Simon, et al.
Publicado: (2023)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Incidence of venous thromboembolism in hospitalized patients with COVID‐19
por: Middeldorp, Saskia, et al.
Publicado: (2020)

Rivaroxaban for cancer-associated venous thromboembolism
por: Liang, Bo, et al.
Publicado: (2021)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
por: Di, Wenjuan, et al.
Publicado: (2021)

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Through thick and thin: Risk of venous thromboembolism vs bleeding after abdominal transplant
por: Whitrock, Jenna N., et al.
Publicado: (2023)

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
por: Willems, R. A. L., et al.
Publicado: (2023)

HIV-Associated Venous Thromboembolism
por: Bibas, Michele, et al.
Publicado: (2011)

Venous Thromboembolism and Travel: Is There an Association?
por: Milne, Ruairidh
Publicado: (1992)

Risk Factors and Prediction Models for Venous Thromboembolism in Ambulatory Patients with Lung Cancer
por: Yan, Ann-Rong, et al.
Publicado: (2021)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

Interpretation of the PREVENT study findings on the adjunctive role of intermittent pneumatic compression to prevent venous thromboembolism
por: Kakkos, Stavros K., et al.
Publicado: (2020)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer
por: Lei, Haike, et al.
Publicado: (2023)

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
por: La Vignera, Sandro, et al.
Publicado: (2020)

Commentary on “Chemoprophylactic anticoagulation 72 hours after spinal fracture surgical treatment decreases venous thromboembolic events without increasing surgical complications”
por: Jiang, Will, et al.
Publicado: (2022)

Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients
por: Rupa-Matysek, Joanna, et al.
Publicado: (2018)

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
por: Muñoz Martín, Andrés J., et al.
Publicado: (2018)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)

Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iod1pctg768bqvdvgi4moig3lh